Dermatophytosis
Introduction
Dermatophytosis, commonly known as ringworm, is a prevalent superficial fungal infection affecting the skin, hair, or nails. These infections are caused by a group of fungi known as dermatophytes, characterized by their unique ability to metabolize keratin, the primary structural protein found in these tissues. While often recognized by the characteristic red, circular rash that gives it the name "ringworm," dermatophytosis can present in various forms depending on the affected body part, such as athlete's foot (tinea pedis), jock itch (tinea cruris), or scalp ringworm (tinea capitis).
Biological Basis
Dermatophytes are a specific type of mold primarily belonging to the genera Trichophyton, Microsporum, and Epidermophyton. These fungi thrive in warm, moist environments and colonize the keratinized layers of the epidermis, hair follicles, and nail plates. They produce enzymes, notably keratinases, which break down keratin, enabling them to penetrate and proliferate within these tissues. Transmission typically occurs through direct contact with an infected individual or animal, or indirectly via contaminated fomites such as towels, clothing, or public shower floors. Susceptibility to these infections can be influenced by various factors, including individual genetic predispositions that may impact immune responses or the integrity of the skin barrier.
Clinical Relevance
Clinically, dermatophytosis manifests with symptoms that can include itching, scaling, erythema (redness), and in some cases, hair loss or nail discoloration and thickening. Diagnosis is typically established through clinical examination, often supported by microscopic examination of skin scrapings (potassium hydroxide prep) or fungal culture for species identification. Treatment strategies involve the application of topical antifungal medications or, for more extensive or recalcitrant infections, systemic oral antifungal agents. While generally not life-threatening, untreated or severe infections can lead to significant discomfort, secondary bacterial infections, and a notable impact on an individual's quality of life. Recurrence is common, especially in individuals with ongoing exposure or predisposing conditions.
Social Importance
Dermatophytosis represents one of the most common infectious diseases globally, affecting millions of people across diverse populations. Its high prevalence, particularly in warm and humid climates, coupled with its contagious nature, contributes to its public health significance. Although often perceived as a minor ailment, chronic or widespread infections can cause considerable discomfort, embarrassment, and social stigma, particularly when visible areas like the scalp or face are affected. The economic burden includes healthcare costs associated with diagnosis and treatment, as well as potential productivity losses. A comprehensive understanding of genetic susceptibilities and transmission dynamics is essential for developing effective prevention strategies, managing outbreaks, and implementing targeted public health interventions.
Methodological and Cohort-Specific Constraints
The current research on dermatophytosis, inferred from the study's general methodology, is subject to several design and cohort-specific limitations. A primary constraint stems from the reliance on electronic medical record (EMR) data collected exclusively from a single academic medical center in Taiwan. [1] This single-center approach inherently restricts the generalizability of findings, as the patient population may not fully represent the broader Taiwanese or global populations, potentially introducing selection bias specific to the hospital's catchment area and referral patterns. Furthermore, the study's design as a hospital-centric database means that the cohort primarily comprises individuals with documented diagnoses, leading to an absence of truly "subhealthy" individuals in the control groups. [1] This characteristic could skew comparisons, as control participants may have other health conditions that confound genetic associations, thereby impacting the accuracy of effect size estimates and the interpretation of disease risk.
The predictive power of polygenic risk score (PRS) models, crucial for understanding genetic architecture, was also observed to correlate with cohort size. [1] For diseases with smaller case numbers, this implies that the PRS models might exhibit lower efficacy, potentially limiting the robustness and reliability of the genetic associations identified. This variability in model performance underscores a statistical constraint where insufficient sample sizes for certain phenotypes could lead to less precise estimates of genetic effects or even missed associations, thereby affecting the comprehensive understanding of dermatophytosis's genetic underpinnings. The inconsistent number of variants selected for PRS models across different diseases, ranging from a single variant to tens of thousands, further highlights this variability, suggesting that the complexity captured by the models may be uneven, depending on the available data and the specific disease.
Challenges in Phenotypic Definition and Ascertainment
The ascertainment of dermatophytosis cases and controls, based on EMR data and PheCode classifications, presents inherent challenges that could affect the accuracy of findings. The diagnostic recording in Taiwan's healthcare system can be influenced by physician decisions, potentially leading to the documentation of unconfirmed diagnoses. [1] To mitigate false positives, the study implemented a stringent criterion requiring three or more diagnoses for case inclusion, but this approach still relies on the initial diagnostic accuracy within the EMR system. [1] While this method aimed to reduce misclassification, the absence of more comprehensive phenotyping criteria, such as a combination of diagnosis, medication history, and laboratory test results, could mean that the disease definitions are not as precise as they could be, potentially affecting the specificity of identified genetic associations.
Moreover, the retrospective nature of EMR data collection inherently carries the risk of unrecorded comorbidities, which could lead to false-negative outcomes in both case and control groups. [1] Although the researchers suggested that the impact of false-negative results might be negligible due to the generally low prevalence of many diseases, the potential for such misclassification remains. This limitation impacts the interpretation of genetic associations by introducing noise into the case/control stratification, making it more challenging to discern true genetic signals from those influenced by unmeasured clinical factors. Future studies could benefit from more rigorous and multifaceted phenotyping to enhance the accuracy of disease classification and reduce the impact of these measurement concerns.
Generalizability and Unexplained Genetic Variance
The genetic findings, particularly regarding PRS models, may have limited generalizability beyond the studied population due to ancestry-specific genetic architectures. The study highlighted discrepancies in effect sizes for specific variants, such as rs6546932 in the SELENOI gene, between the Taiwanese Han population and European populations (e.g., UK Biobank), emphasizing that genetic effects can vary significantly across different ancestral backgrounds. [1] This indicates that PRS models developed in one population may not accurately predict disease risk in others, underscoring the need for ancestry-specific validation and development of such models. Consequently, the observed genetic associations and risk predictions for dermatophytosis in the Taiwanese Han population may not be directly transferable to populations of different ancestries without further investigation.
Furthermore, the predictive power of PRS models for many diseases, including those with genetic components, showed modest performance, with AUC values often around 0.6. [1] This suggests that the current genetic architecture captured by the identified variants explains only a limited proportion of the overall disease risk. Such findings point towards significant remaining knowledge gaps and potential missing heritability, where a substantial portion of the genetic variance contributing to dermatophytosis susceptibility is yet to be discovered. This could be due to unexamined rare variants, complex gene-environment interactions not accounted for, or epigenetic factors that are not captured by current GWAS methodologies, indicating that a complete understanding of the disease's genetic landscape requires more extensive and diverse research.
Variants
Genetic variations play a crucial role in an individual's susceptibility to various conditions, including dermatophytosis, by influencing immune responses, skin barrier integrity, and metabolic pathways. The PRSS53 gene (Serine Protease 53) encodes a protease primarily expressed in the skin, where it is involved in epidermal differentiation and desquamation. Variants such as rs17839568 and rs11864806 in PRSS53 could alter its enzymatic activity, potentially compromising the skin's natural barrier function or leading to dysregulated inflammatory responses. Similarly, ZNF646 (Zinc Finger Protein 646) acts as a transcription factor, regulating the expression of genes involved in cellular processes, including those vital for skin health and immune cell development, where variations might indirectly affect the body's defense against fungal pathogens.. [1] Such disruptions can create a more permissive environment for dermatophyte colonization and infection, underscoring the complex interplay between genetic factors and environmental challenges.. [1]
The FTO (Fat Mass and Obesity-associated) gene is widely recognized for its strong association with obesity and metabolic traits, including type 2 diabetes, hypertension, and hyperlipidemia. While specific information on rs1421085 was not detailed, the FTO gene itself has been significantly associated with metabolic conditions, which can indirectly impact immune function and skin health. [1] Metabolic dysregulation can impair the skin's healing capacity and immune surveillance, making individuals more vulnerable to infections like dermatophytosis. Furthermore, the HLA-DQB1 gene, part of the Human Leukocyte Antigen (HLA) complex, is fundamental for presenting antigens to T-cells, thereby initiating adaptive immune responses. Variants like rs1794269 in HLA-DQB1 can lead to altered immune recognition, affecting how the body identifies and responds to fungal antigens and predisposing individuals to autoimmune or inflammatory conditions, which can overlap with dermatological vulnerabilities.. [1]
Variations in genes critical for skin barrier function, such as FLG (Filaggrin), significantly influence susceptibility to dermatological conditions. For instance, rs61816761 in FLG can impair the production of filaggrin, a protein essential for maintaining the epidermal barrier and skin hydration. A compromised skin barrier provides an easier entry point for dermatophytes, increasing the risk of infection and potentially contributing to more severe or persistent disease.. [1] Similarly, the CCDST gene, encompassing variant rs12123821, encodes a protein with coiled-coil domains, often indicative of roles in structural integrity or protein-protein interactions within cells. While its direct link to dermatophytosis is less understood, any genetic variation that subtly affects epidermal structure, cellular signaling, or the overall resilience of skin cells could contribute to an increased susceptibility to fungal invasion.. [1]
Other variants, such as rs4689388 associated with JAKMIP1-DT and WFS1, or rs55818528 linked to LYNX1-SLURP2 and LY6D, may contribute to dermatophytosis susceptibility through diverse mechanisms. WFS1 is involved in endoplasmic reticulum stress and calcium homeostasis, processes vital for cell survival and function, including immune cells. LY6D plays a role in cell surface signaling and immune regulation, potentially influencing inflammatory responses or pathogen recognition in the skin.. [1] Additionally, variants like rs73984689 in KANSL1, which is involved in chromatin remodeling and gene expression, or rs62106252 in the long intergenic non-coding RNA LINC01865, could broadly impact cellular pathways, immune cell development, or the skin's overall defense mechanisms. These genetic alterations, uncovered through extensive genetic studies, highlight the intricate molecular landscape that governs an individual's response to dermatophyte infections.. [1]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs17839568 | PRSS53 | dermatophytosis tinea unguium |
| rs11864806 | ZNF646, PRSS53 | dermatophytosis |
| rs1421085 | FTO | body mass index obesity energy intake pulse pressure measurement lean body mass |
| rs1794269 | HLA-DQB1 - MTCO3P1 | peptidoglycan recognition protein 1 measurement diabetic eye disease rheumatoid arthritis, chronic interstitial cystitis rheumatoid arthritis, hypothyroidism dermatophytosis |
| rs12123821 | CCDST | non-melanoma skin carcinoma asthma susceptibility to plantar warts measurement allergic disease mosquito bite reaction itch intensity measurement |
| rs61816761 | CCDST, FLG | asthma childhood onset asthma allergic disease sunburn vitamin D amount |
| rs4689388 | JAKMIP1-DT - WFS1 | type 2 diabetes mellitus diabetes mellitus dermatophytosis tinea unguium |
| rs55818528 | LYNX1-SLURP2 - LY6D | dermatophytosis |
| rs73984689 | KANSL1 | hematocrit hemoglobin measurement COVID-19 symptoms measurement dermatophytosis |
| rs62106252 | LINC01865 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement diet measurement dermatophytosis potassium measurement chloride amount |
Conceptual Framework and Nomenclature in Clinical Research
Dermatophytosis, as a dermatological condition, is conceptualized within large-scale genetic studies as a distinct phenotype requiring precise identification for research purposes. [1] The nomenclature for such conditions is critical for data standardization, enabling consistent categorization across diverse patient populations and longitudinal records. While specific trait definitions for dermatophytosis are not detailed, its inclusion in a study involving 1085 phenotypes implies its recognition as a definable health outcome within a comprehensive medical framework. [1] The China Medical University Hospital (CMUH) study, which included a Department of Dermatology, underscores the clinical relevance and distinct identity of dermatological diseases like dermatophytosis. [1]
Standardized Disease Classification Systems
The classification of dermatophytosis within the context of large-scale epidemiological and genetic studies relies heavily on standardized nosological systems. [1] In the China Medical University Hospital cohort, disease data, including dermatological conditions, were archived using both the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). [1] These systems provide a hierarchical, categorical approach to disease classification, ensuring uniformity in medical record keeping and facilitating retrospective analyses of patient data. [1]
For research purposes, these ICD codes were further integrated into the PheCode system, a more granular classification scheme designed for phenome-wide association studies (PheWAS). [1] A total of 58,257,251 ICD-9-CM or ICD-10-CM diagnostic codes were combined into 1791 PheCodes, which were then narrowed to 1085 phenotypes for specific analyses. [1] This conversion allows for a dimensional approach to disease classification, mapping clinical diagnoses to research-ready phenotypes, and enabling robust genetic association studies, where dermatophytosis would be represented by its corresponding PheCode. [1]
Diagnostic and Operational Criteria
In the study, the operational definition and diagnostic criteria for dermatophytosis, like all other analyzed diseases, adhered to the PheCode criteria. [1] A crucial aspect of establishing a confirmed diagnosis for research inclusion was the requirement that these PheCode criteria be met on at least three distinct occasions. [1] This rigorous approach aimed to enhance diagnostic accuracy and reduce misclassification rates within the large patient cohort, ensuring that only robustly identified cases of dermatophytosis, among other conditions, were included in the case groups. [1]
This methodological criterion serves as a research-specific threshold, differentiating confirmed disease states from incidental or transient observations in electronic medical records (EMRs). [1] While specific clinical criteria or biomarkers for dermatophytosis are not detailed in this context, the reliance on repeated PheCode diagnoses acts as a standardized measurement approach, defining the presence of the trait for genetic analysis. [1] This uniform application of diagnostic stringency across all 1085 phenotypes ensures consistency in data interpretation for polygenic risk modeling and disease association studies. [1]
Causes of Dermatophytosis
Dermatophytosis, a common fungal infection affecting the skin, hair, and nails, arises from a complex interplay of genetic predispositions, demographic factors, and gene-environment interactions. While the causative agents are dermatophyte fungi, individual susceptibility varies significantly.
Genetic Predisposition and Polygenic Risk
Genetic factors play a substantial role in an individual's susceptibility to dermatophytosis. Research indicates that diseases affecting the integumentary (dermatology) systems are associated with a significant number of genes, suggesting a polygenic architecture. [1] This means that inherited variants across multiple genes, rather than a single gene, contribute to the overall risk. Although specific genes directly linked to dermatophytosis were not detailed, the broader category of dermatological conditions demonstrates a clear genetic component in disease susceptibility within populations such as the Taiwanese Han. [1] This inherent genetic architecture, involving various gene-gene interactions, influences the efficacy of the immune response and the structural integrity of the skin, thereby modulating an individual's innate resistance or susceptibility to fungal invasion.
Demographic and Age-Related Influences
Demographic factors, particularly age and sex, are significant contributors to the incidence and presentation of various diseases, including dermatological conditions. The incidence of most diseases generally increases with age, implying that older individuals may experience a heightened risk of dermatophytosis due to age-related changes in immune function, skin barrier integrity, or comorbidities. [1] Furthermore, while the overall gender distribution in control groups for many traits is relatively balanced, sex can also exert a significant effect on disease risk and manifestation. [1] These age-related changes and sex-specific differences represent crucial clinical features that influence an individual's overall vulnerability to dermatophyte infections.
Gene-Environment Interactions
The development of dermatophytosis is often a result of intricate gene-environment interactions, where an individual's genetic predisposition is modulated by external factors. Studies highlight the importance of considering ancestry-specific genetic architectures, as genetic effects can vary across different populations. [1] Polygenic risk score models, which integrate multiple genetic variants, are often adjusted for confounding factors such as age and sex, emphasizing the dynamic interplay between inherited traits and environmental exposures. [1] This suggests that while genetic factors confer a baseline susceptibility, the actual manifestation and severity of dermatophytosis can be significantly influenced by various environmental triggers, although specific environmental factors for dermatophytosis were not detailed in the provided context.
Large-scale Cohort Studies and Longitudinal Insights
Population studies leveraging extensive biobanks and electronic medical records (EMRs) provide crucial insights into disease architecture and temporal patterns. The HiGenome cohort, established in Taiwan, represents a significant large-scale study focused on the Taiwanese Han population, comprising 323,397 participants with ongoing recruitment. [1] This cohort benefits from deeply integrated physician-documented EMRs spanning from 2003 to 2021, offering up to 19 years of longitudinal follow-up for a substantial portion of participants; approximately 85.9% were followed for over a year, and 27.9% for more than 15 years. [1] The volume of diagnostic instances within this dataset dramatically increased from 800,000 in 2003 to around 7 million by 2021, demonstrating its rich temporal data for studying disease progression and incidence. [1]
Unlike some other large biobanks, such as the UK Biobank (UKBB) and the Million Veteran Program (MVP), which often integrate questionnaire-based self-reported information alongside clinical data, the HiGenome cohort primarily relies on detailed EMRs. [1] This approach enhances data accuracy and disease classification, particularly for chronic and progressive conditions where multiple clinical visits refine diagnoses over time, thereby minimizing potential recall bias associated with self-reported data. [1] The cohort's comprehensive clinical records, combined with extensive genetic data, establish it as one of the most substantial East Asian (EAS) genetic datasets with integrated longitudinal clinical information. [1]
Epidemiological and Demographic Patterns
Epidemiological analyses within large cohorts reveal key demographic associations with disease patterns. In the Taiwanese Han population study, the overall male-to-female ratio was 45.3:54.7. [1] For most diseases, a consistent trend showed that incidence increased with age and time, with disease groups generally exhibiting a higher median age compared to control groups. [1] While the control group's male proportion consistently ranged between 0.49 and 0.42, reflecting the cohort's overall gender distribution, specific traits sometimes showed marked gender disparities in the case groups. [1]
Cross-population comparisons and ancestry analyses are also integral to understanding disease distribution. The HiGenome cohort predominantly consists of individuals of East Asian (EAS) ancestry, with principal component analysis (PCA) revealing predominant ancestral lineages mapped to Southern Han Chinese individuals, followed by Han Chinese from Beijing, Chinese Dai, Kinh from Vietnam, and Japanese individuals. [1] A small subset of participants also showed ancestry resembling individuals from Utah with northern or western European descent. [1] This diverse EAS genetic background necessitates PCA adjustment in genetic analyses to account for population structure and ensure the robustness of findings. [1]
Methodological Approaches and Considerations
The methodology of large-scale population studies is critical for the validity and generalizability of their findings. The HiGenome study utilized a retrospective analysis of patient EMRs collected from China Medical University Hospital (CMUH) and its affiliated branches. [1] Medical diagnoses were established based on International Classification of Diseases (ICD-9-CM and ICD-10-CM) codes, which were then mapped to PheCode criteria, requiring at least three distinct diagnostic occasions for disease classification. [1] Control groups were defined as individuals without PheCode-defined diseases, ensuring a robust comparison. [1]
Genetic data were obtained using a custom Axiom TPMv1 SNP array, supplemented by whole-genome sequencing and imputation techniques, expanding the dataset to nearly 14 million reference points. [1] Genome-Wide Association Studies (GWASs) and Phenome-Wide Association Studies (PheWASs) were conducted, with logistic regression models adjusted for confounders such as age, sex, and PCA results. [1] The study's design, which integrates detailed EMRs and comprehensive genetic profiling, provides a strong foundation for exploring genetic predispositions to common diseases within a specific population, while acknowledging that its focus on a single institution and a primarily Taiwanese Han population influences its representativeness and generalizability to broader populations. [1]
Frequently Asked Questions About Dermatophytosis
These questions address the most important and specific aspects of dermatophytosis based on current genetic research.
1. Why do I keep getting ringworm when my friend never does?
Yes, some people are genetically more prone to ringworm. Your genes can influence how strong your immune system is or how robust your skin barrier is, making it easier for the fungi to take hold and cause recurring infections compared to others.
2. Can my family history make me more likely to get athlete's foot?
Absolutely. A family history of fungal infections can indicate a genetic predisposition. Your genes can affect your natural defenses, like your immune response or the integrity of your skin barrier, making you more susceptible to infections like athlete's foot.
3. Does my ethnic background change my risk of getting ringworm?
It can. Research shows that genetic risk factors for infections like ringworm can differ significantly across various ancestral populations. For example, a specific variant like rs6546932 in the SELENOI gene might have different effects in Taiwanese Han populations compared to European populations, highlighting the importance of ancestry-specific studies.
4. If I'm careful, can I still get ringworm often due to my genes?
Even with good hygiene, your genes play a role. If you have genetic predispositions that affect your immune response or skin barrier, you might be more vulnerable to infection even with typical exposure. However, careful practices still significantly reduce your overall risk.
5. Why do some people just seem immune to these skin infections?
Some individuals are indeed more naturally resistant due to their genetic makeup. Their genes might provide them with a stronger immune response or a more resilient skin barrier, making it harder for dermatophytes to establish an infection and cause symptoms.
6. Could a DNA test tell me if I'm at high risk for ringworm?
While genetic testing for ringworm risk is an emerging area, polygenic risk scores (PRS) are being developed to assess susceptibility based on multiple genetic variants. However, their predictive power can vary depending on the population studied and the number of variants included, so they are not yet widely used clinically for this specific purpose.
7. Why does my sibling get ringworm often, but I don't?
Even within families, individual genetic variations can lead to different susceptibilities. You and your sibling might have inherited different genetic predispositions affecting your immune systems or skin barriers, explaining why one is more prone to infection than the other.
8. Does living in a warm, humid place make my genetic risk worse?
Yes, environmental factors like warmth and humidity interact with your genetic predispositions. While your genes might make you susceptible, these external conditions create the ideal environment for the fungi to thrive and initiate an infection, amplifying your risk.
9. If my skin gets easily irritated, am I more prone to ringworm?
Potentially, yes. Genetic factors can influence the integrity and overall health of your skin barrier. If your skin barrier is genetically weaker or more prone to irritation, it might offer less protection against fungal invasion, increasing your susceptibility.
10. Can I pass on a tendency for ringworm to my children?
Yes, genetic predispositions for conditions like ringworm can be inherited. If you have genetic factors that make you more susceptible, there's a possibility your children could inherit similar genetic influences on their immune response or skin barrier, increasing their potential risk.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Liu TY et al. "Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population." Sci Adv. 2025.